BrickBio
Boston
About BrickBio
BrickBio is a developer of a bioconjugation platform intended for research of site-specific modification of proteins. The company's platform can optimize any conjugate with the selective modification of a number of distinct websites on a single protein through its prokaryotic and eukaryotic expression programs, thereby providing hospitals with amino acid coupled therapeutics to improve protein characteristics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Last round: Series Unknown (Mar 2024)
- Website: brickbio.com
- Phone: (212) 984-2548
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/brickbio-24539 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.